Florey Biosciences, Inc. — Form D
Florey Biosciences, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-29. The offering totals $4.4M, of which $1.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-04-29
- Form: D
- Accession: 0002066011-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.4M
- Amount sold: $1.4M
- Remaining: $3.0M
- Investors: 1
- Date of first sale: 2025-04-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-544696
Issuer
- Name: Florey Biosciences, Inc.
- CIK: 0002066011
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 160 ALEWIFE BROOK PKWY #1378, CAMBRIDGE, MA, 02138
- Phone: 603-306-1237
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Andres Fernando Cubillos Ruiz | Director | Cambridge, MA |
| Peter Fernando Hutt | Director | Cambridge, MA |
| Mark Fernando Smith | Director | Cambridge, MA |
| Andres Fernando Cubillos Ruiz | Executive Officer | Cambridge, MA |
| Raphael Fernando Gayet | Executive Officer | Cambridge, MA |
More